Trial Profile
Retrospective study of Vaccell in Pancreatic cancer patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs Tumour peptide-loaded dendritic cell vaccine Tella (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Tella
- 25 Feb 2016 New trial record